Those with the altered gene (RNF43) may benefit from drugs that target the wrt pathway, which are currently in clinical trial.
http://www.dana-farber.org/Newsroom/News-Releases/Unsuspected-gene-found-frequently-mutated-in-colorectal-endometrial-cancers.aspx